Shanghai Fosun Pharmaceutical Group Co Ltd Market Cap ($7.33 Billion)
Market Cap & Net Worth: Shanghai Fosun Pharmaceutical Group Co Ltd (600196)
Shanghai Fosun Pharmaceutical Group Co Ltd market cap. Shanghai Fosun Pharmaceutical Group Co Ltd (SHG:600196) has a market capitalization of $7.33 Billion (CN¥50.12 Billion) as of November 6, 2026. Listed on the SHG stock exchange, this China-based company holds position #2705 globally and #296 in its home market, demonstrating a 2.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Fosun Pharmaceutical Group Co Ltd's stock price CN¥23.66 by its total outstanding shares 2118488825 (2.12 Billion). Also see 600196 cash flow conversion for how efficiently the company converts equity into cash flow.
Shanghai Fosun Pharmaceutical Group Co Ltd Market Cap History (2015–2026)
Shanghai Fosun Pharmaceutical Group Co Ltd market cap history from 2015 to 2026. Data shows change from $6.64 Billion to $7.33 Billion (-0.05% CAGR). Check latest Shanghai Fosun Pharmaceutical Group Co L stock price today for real-time trading data and today's change.
Index Memberships
Shanghai Fosun Pharmaceutical Group Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.00 Trillion | 0.18% | #99 of 285 |
Weight: Shanghai Fosun Pharmaceutical Group Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shanghai Fosun Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Fosun Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Shanghai Fosun Pharmaceutical Group Co L annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.20x
Shanghai Fosun Pharmaceutical Group Co Ltd's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.44x
Shanghai Fosun Pharmaceutical Group Co Ltd's market cap is 2.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.65 Billion | $14.63 Billion | $2.81 Billion | 0.45x | 2.37x |
| 2017 | $12.95 Billion | $18.53 Billion | $3.12 Billion | 0.70x | 4.15x |
| 2018 | $6.85 Billion | $24.92 Billion | $2.71 Billion | 0.27x | 2.53x |
| 2019 | $7.92 Billion | $28.59 Billion | $3.32 Billion | 0.28x | 2.39x |
| 2020 | $16.19 Billion | $30.31 Billion | $3.66 Billion | 0.53x | 4.42x |
| 2021 | $14.76 Billion | $39.01 Billion | $4.73 Billion | 0.38x | 3.12x |
| 2022 | $10.77 Billion | $43.95 Billion | $3.73 Billion | 0.25x | 2.89x |
| 2023 | $7.76 Billion | $41.40 Billion | $2.39 Billion | 0.19x | 3.25x |
| 2024 | $7.70 Billion | $41.07 Billion | $2.77 Billion | 0.19x | 2.78x |
| 2025 | $8.21 Billion | $41.50 Billion | $3.37 Billion | 0.20x | 2.44x |
Competitor Companies of 600196 by Market Capitalization
Companies near Shanghai Fosun Pharmaceutical Group Co Ltd in the global market cap rankings as of November 6, 2026. Also see Shanghai Fosun Pharmaceutical Group Co L assets under control for a full breakdown of the balance sheet.
Key companies related to Shanghai Fosun Pharmaceutical Group Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #506 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #532 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #570 globally with a market cap of $46.85 Billion USD ( CN¥320.16 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #506 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #532 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.40 |
| #570 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.85 Billion | CN¥50.19 |
| #615 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €19.30 |
Market Capitalization of Shanghai Fosun Pharmaceutical Group Co Ltd (2015–2026)
Market capitalization of Shanghai Fosun Pharmaceutical Group Co Ltd from 2015 to today. Between 2015 and today, Shanghai Fosun Pharmaceutical Group Co Ltd's market cap moved from $6.64 Billion to $ 7.33 Billion, with a yearly change of -0.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥7.33 Billion | -10.68% |
| 2025 | CN¥8.21 Billion | +6.60% |
| 2024 | CN¥7.70 Billion | -0.72% |
| 2023 | CN¥7.76 Billion | -27.97% |
| 2022 | CN¥10.77 Billion | -27.04% |
| 2021 | CN¥14.76 Billion | -8.82% |
| 2020 | CN¥16.19 Billion | +104.40% |
| 2019 | CN¥7.92 Billion | +15.74% |
| 2018 | CN¥6.85 Billion | -47.15% |
| 2017 | CN¥12.95 Billion | +94.66% |
| 2016 | CN¥6.65 Billion | +0.20% |
| 2015 | CN¥6.64 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Shanghai Fosun Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.33 Billion USD |
| MoneyControl | $7.33 Billion USD |
| MarketWatch | $7.33 Billion USD |
| marketcap.company | $7.33 Billion USD |
| Reuters | $7.33 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Fosun Pharmaceutical Group Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumor… Read more